Arteriosclerosis Obliterans
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
RNA Therapeutic
2100%
Competitive Landscape
2 companies ranked by most advanced pipeline stage
1 program
Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep N/ARNA Therapeutic1 trial
Active Trials
Innovation PharmaceuticalsMA - Wakefield
1 programPreoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep N/ARNA Therapeutic
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GE HealthCarePreoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep
Clinical Trials (1)
Total enrollment: 103 patients across 1 trials
NCT00712946GE HealthCarePreoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep
Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages
Start: Mar 2006Est. completion: Dec 2010103 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.